Evidence map›Paper›PMID 39124951›Full record

ArticleMolecules (Basel, Switzerland)2024

Dual-Functionalized Mesoporous Silica Nanoparticles for Celecoxib Delivery: Amine Grafting and Imidazolyl PEI Gatekeepers for Enhanced Loading and Controlled Release with Reduced Toxicity.

Diky Mudhakir, Ebrahim Sadaqa, Zuliar Permana, Jihan Eldia Mumtazah, Normalita Faraz Zefrina, Jovinka Natalie Xeliem, Latifa Fawzia Hanum, Neng Fisheri Kurniati

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Fluorescent superparamagnetic magnetite-silica nanocomposites as carriers of a platinum diimine complex for photodynamic therapy.Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine · 2025
    Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Diky MudhakirDepartment of Pharmaceutics, School of Pharmacy, Institut Teknologi Bandung (ITB), Bandung 40132, Indonesia.ORCID 0000-0002-1081-5241
Ebrahim SadaqaDepartment of Pharmaceutics, School of Pharmacy, Institut Teknologi Bandung (ITB), Bandung 40132, Indonesia.ORCID 0000-0002-5169-4271
Zuliar PermanaDepartment of Pharmaceutics, School of Pharmacy, Institut Teknologi Bandung (ITB), Bandung 40132, Indonesia.
Jihan Eldia MumtazahDepartment of Pharmaceutics, School of Pharmacy, Institut Teknologi Bandung (ITB), Bandung 40132, Indonesia.
Normalita Faraz ZefrinaDepartment of Pharmaceutics, School of Pharmacy, Institut Teknologi Bandung (ITB), Bandung 40132, Indonesia.ORCID 0009-0002-4184-5635
Jovinka Natalie XeliemDepartment of Pharmaceutics, School of Pharmacy, Institut Teknologi Bandung (ITB), Bandung 40132, Indonesia.
Latifa Fawzia HanumDepartment of Pharmaceutics, School of Pharmacy, Institut Teknologi Bandung (ITB), Bandung 40132, Indonesia.
Neng Fisheri KurniatiDepartment of Clinical and Community Pharmacy, School of Pharmacy, Institut Teknologi Bandung (ITB), Bandung 40132, Indonesia.

Funding

Research, Community Service and Innovation (P2MI) School of Pharmacy, Institut Teknologi Bandung (ITB) 31/IT1.C10/SK-KU/2024
6 · The paper itself

Abstract

The development of targeted drug delivery systems has been a pivotal area in nanomedicine, addressing challenges like low drug loading capacity, uncontrolled release, and systemic toxicity. This study aims to develop and evaluate dual-functionalized mesoporous silica nanoparticles (MSN) for targeted delivery of celecoxib, enhancing drug loading, achieving controlled release, and reducing systemic toxicity through amine grafting and imidazolyl polyethyleneimine (PEI) gatekeepers. MSN were synthesized using the sol-gel method and functionalized with (3-aminopropyl) triethoxysilane (APTES) to create amine-grafted MSN (MSN-NH

Indexed as

AminesCelecoxibDelayed-Action PreparationsDrug LiberationNanoparticlesPolyethyleneimineSilicon DioxideAnimalsCell SurvivalDrug CarriersDrug Delivery SystemsHydrogen-Ion ConcentrationImidazolesMicePorosityRAW 264.7 CellsAminesCelecoxibDelayed-Action PreparationsDrug CarriersImidazolesPolyethyleneimineSilicon Dioxideanti-inflammatory agentcytotoxicityimidazolyl-PEIloading drugmesoporous silica nanoparticles

Identifiers

PMID39124951
PMCPMC11313749

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.